Homatropine hydrocodone buy soma
Sales from our international operations during the nine month period ended December 31, 2012 were spread across the United States (34.7%), Europe (42.5%) and ROW (22.8%). We homatropine hydrocodone buy soma have extended our business operations across various countries and believe that this diversification allows us to maintain a homatropine hydrocodone buy soma targeted approach towards international markets while simultaneously reducing regulatory and other risks during adverse market conditions or risks homatropine hydrocodone buy soma arising from concentration in any single jurisdiction. Our marketing and distribution network in India comprises a specialized team of over 2,900 sales representatives, which enables us to market our products to over 150,000 doctors across various specialties.
Our domestic distribution network includes 36 sales depots and approximately 4,000 stockists. We also market our products to various hospitals and medical institutions, which constitute an important channel for the distribution of our products. Our domestic marketing infrastructure consists of 20 dedicated teams, which formulate marketing and promotional strategies for our products. We believe that our marketing strategies, trained sales representatives and distribution network enable us to increase our market share across key therapy areas and build and develop our brands such as Zoryl, Ceftas, Hifenac, Lipicure, Levera, Valprol and Amtas.
We have the capability to develop and build megabrands, which are brands that IMS categorizes as being among the top 300 pharmaceutical brands in India, in terms hydrocodone apap 10mg 650mg of sales.
According to IMS, three of our brands, Levera, Lipicure and Zoryl-M, were among the top selling 300 pharmaceutical brands in India in the 12 month period ended December 2012 (Source: IMS SSA, December 2012 MAT.). Internationally, our products are marketed in homatropine hydrocodone buy soma over 60 countries, including in major regulated markets such as the United States and Europe through our own marketing and distribution network as well as by entering into alliances with leading global pharmaceutical companies that have significant experience in these markets.
We have an established presence in Europe, with marketing infrastructure in the homatropine hydrocodone buy soma U.K., the Netherlands, Germany, Spain, France and Italy. As of December 31, 2012 we held over 3,300 marketing authorizations across various international markets. We believe that our product selection strategy has facilitated rapid growth in this market and we crossed U.S.$80 million in sales in the nine month period ended 31 December, 2012. We believe that our products are sold through leading distributors and retail pharmacy chains across the United States. We have also diversified into markets which we believe are key growth markets such as Brazil, Mexico, Canada, Australia, New Zealand and South Africa. We have also entered into over 300 out-licensing arrangements and long term supply agreements with several global pharmaceutical companies, including Teva, Sandoz, Apotex, Gedeon Richter and Hikma.
Us pharmacy phentermine
Paracetamol and tramadol
Hydrocodone chemical formula